AIGHD Director, Prof. Frank Cobelens, and colleagues publish review in the Lancet Infectious Disease insisting on the acceleration of research and development for a vaccine against Tuberculosis. For centuries, tuberculosis (TB) has infected 10 million people annually and been the leading cause of death around...
The PAVIA project, led by Prof. Frank Cobelens, was recently featured in a publication of the Uppsala Reports highlighting the evolution of the project since its beginning within the Kingdom of Eswatini. Funded by the European Developing Countries Clinical Trials Partnership (EDCTP), PAVIA focuses on improving...
AIGHD research fellow, Tobias Rinke de Wit, participated in an event 22 February on how evolutionary medicine helps explain regional differences in pandemic dynamics: immunity, symbiosis, and COVID-19. Data has been mounting for more than 50 years pointing toward the importance of “complex eukaryotic symbionts” in...
A new study looking at the presence of pharmaceuticals in the world’s rivers found concentrations at potentially toxic levels in more than a quarter of the locations studied. The new study looked at 258 rivers across the globe, including the Thames in London and the Amazon...
A recent systematic analysis of the global burden of bacterial antimicrobial resistance published in The Lancet last week shows that antimicrobial resistance (AMR) poses a major threat to human health around the world, with the largest burden in sub-Saharan Africa and South Asia. The study includes...
Partners of AMR-Global have been awarded funding to carry out a research program on antimicrobial resistance. The collaboration is co-funded by the PPP Allowance made available by Health~Holland, Top Sector Life Sciences & Health, to stimulate public-private partnerships. The program is titled “AMR-Global: Reducing inappropriate...
Just last month, PhD Fellow for the AGEhIV Cohort Study, Myrthe Verburgh, had a paper accepted into the Journal of Infectious Diseases on SARS-CoV-2 incidence in the AGEhIV Cohort. The study concluded that there was a similar risk of SARS-CoV-2 infection among both HIV-positive and...
“I look back when talking to my children and realize that collaboration was a turning point in my life. I’ve been blessed to work with top-notch scientists including the late Dr. Joep Lange. You know, the best of the best. Nothing takes that away. Those...
INTEREST 2020 Joep Lange Award winner, Dr. Joseph Baruch Baluku, recently published an editorial recapping INTEREST 2021 while simultaneously providing insight on the ongoing fight against HIV in Africa. The editorial was published in Therapeutic Advances in Infectious Disease. The full editorial can be found...
For the third year, AIGHD and the Joep Lange Institute (JLI) successfully organized the annual Joep Lange Chair and Fellows Masterclass. The class is comprised of late-stage PhD students and early-stage researchers led by Masters in global health from around the world. After submitting their...